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Abstract
The consumption of red meat is probably carcinogenic to humans and is associated with an increased risk to develop
colorectal cancer (CRC). Red meat contains high amounts of heme iron, which is thought to play a causal role in tumor
formation. In this study, we investigated the genotoxic and cytotoxic effects of heme iron (i.e., hemin) versus inorganic
iron in human colonic epithelial cells (HCEC), human CRC cell lines and murine intestinal organoids. Hemin catalyzed
the formation of reactive oxygen species (ROS) and induced oxidative DNA damage as well as DNA strand breaks in
both HCEC and CRC cells. In contrast, inorganic iron hardly affected ROS levels and only slightly increased DNA
damage. Hemin, but not inorganic iron, caused cell death and reduced cell viability. This occurred preferentially in
non-malignant HCEC, which was corroborated in intestinal organoids. Both hemin and inorganic iron were taken up
into HCEC and CRC cells, however with differential kinetics and efficiency. Hemin caused stabilization and nuclear
translocation of Nrf2, which induced heme oxygenase-1 (HO-1) and ferritin heavy chain (FtH). This was not observed
after inorganic iron treatment. Chemical inhibition or genetic knockdown of HO-1 potentiated hemin-triggered ROS
generation and oxidative DNA damage preferentially in HCEC. Furthermore, HO-1 abrogation strongly augmented the
cytotoxic effects of hemin in HCEC, revealing its pivotal function in colonocytes and highlighting the toxicity of free
intracellular heme iron. Taken together, this study demonstrated that hemin, but not inorganic iron, induces ROS and
DNA damage, resulting in a preferential cytotoxicity in non-malignant intestinal epithelial cells. Importantly, HO-1
conferred protection against the detrimental effects of hemin.
Introduction
Heme is an important iron source in human nutrition
and occurs mainly in food of animal origin such as meat1.
Heme b is the most abundant heme, consisting of a
protoporphyrin ring with a central iron (Fe2+). As such, it
is the prosthetic group of the oxygen transporter proteins
hemoglobin and myoglobin2. The central iron is coordi-
nated by four nitrogen atoms of the protoporphyrin
backbone and a histidine residue of the globin, leaving one
free ligand-binding site for oxygen2. Upon its dietary
uptake, heme is liberated from myoglobin or hemoglobin
due to the acidic pH in the stomach and the enzymatic
proteolysis occurring in both the stomach and duode-
num3. Heme is then internalized into intestinal epithelial
cells, which is likely mediated by a transporter called
heme carrier protein 1 (HCP-1; also known as proton-
coupled folate transporter or PCTF)4,5. In the cytosol, it is
finally catabolized by the enzyme heme oxygenase-1
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(HO-1) to biliverdin, ferrous iron (Fe2+) and carbon
monoxide (CO)6.
In recent years, the dietary uptake of heme iron has
attracted great attention due to its involvement in the
etiology of colorectal cancer (CRC)7. Heme occurs
abundantly in red meat8, whose consumption has been
classified as possibly carcinogenic to humans by the
International Agency for Research on Cancer9. Several
lines of evidence indicate that heme iron is the critical
constituent of red meat driving colorectal tumorigenesis.
The underlying mechanisms are not fully understood, but
include intestinal hyperproliferation10,11, changes in the
gut microbiota12,13 and genotoxic effects triggered by
heme iron14,15. Apart from that, it has been shown that
dietary heme promotes lipid peroxidation and, thus, the
formation of reactive aldehydes such as 4-hydroxynonenal
(4-HNE)16,17. Interestingly, fecal water obtained from
heme-fed rodents or its constituent 4-HNE exhibited a
higher toxicity in normal murine colon epithelial cells
with wildtype APC as compared to pre-neoplastic
cells bearing a mutated APC allele (APCMin/+)17,18. The
cellular resistance to heme triggered cytotoxicity was
mediated by key enzymes responsible for 4-HNE detox-
ification19 and by the activation of the transcription factor
Nrf220, which is known to be engaged by oxidative stress
and electrophilic compounds21.
Surprisingly, the effects induced by heme iron have
never been directly compared to that of inorganic iron in
normal or transformed colonocytes, and it is still unclear
whether heme iron or its cellular breakdown product
ferrous iron is responsible for DNA damage and cyto-
toxicity. In this work, we studied the genotoxic and
cytotoxic potential of heme iron versus inorganic iron in
normal human colonic epithelial cells (HCEC), human
CRC cells lines and murine intestinal organoids. Initially,
the formation of reactive oxygen species (ROS) and
induction of DNA damage was assessed. Next, the impact
of both iron species on cell cycle progression, cell death
induction and cell viability was monitored. Iron uptake in
HCEC and CRC cells was measured by inductively cou-
pled plasma mass spectrometry (ICP-MS) and, indirectly,
via detection of HO-1 expression levels. Finally, we
addressed the role of HO-1 in heme-triggered ROS for-
mation, DNA damage and cytotoxicity in both HCEC and
CRC cells using the HO-1 inhibitor zinc protoporphyrin
(ZnPP) and siRNA mediated knockdown of HO-1.
Results
Heme iron, but not inorganic iron, promotes ROS
production and oxidative DNA damage in HCEC and CRC
cells
First, we investigated the production of ROS in HCEC
and CRC cell lines in response to hemin (Fe3+ proto-
porphyrin chloride) and ferric chloride (FeCl3) treatment
using flow cytometry (Fig. 1a–d). In HCEC, hemin caused
a dose-dependent increase in ROS levels already 30 min
after incubation, with 200 µM hemin resulting in a 25-fold
induction as compared to control cells (Fig. 1a and Sup-
plementary Fig. S1A). The dose-dependent ROS produc-
tion by hemin further increased after 2 h and was still
observed after 24 h, albeit at reduced levels (Fig. 1c;
Supplementary Figs. S1A and S2B). In contrast, ferric iron
only slightly induced ROS formation independent of the
incubation period (Fig. 1a, c and Supplementary Fig. S2B).
Importantly, incubation of HCEC with ferrous iron
(FeSO4) had also no or little effect on cellular ROS levels
(Supplementary Fig. S2A, B). In HCT116 CRC cells,
hemin caused an up to 3-fold upregulation of ROS levels
as compared to control cells after 30 min (Fig. 1b and
Supplementary Fig. S1B), with generally weaker effects as
seen in HCEC. ROS levels further increased over time at
the highest hemin dose (Fig. 1d, Supplementary Figs. S1B
and S2D). Interestingly, FeCl3 hardly affected basal ROS
levels in HCT116 cells (Fig. 1b, d and Supplementary Fig.
S2D). A comparable hemin-dependent increase in ROS
generation was detected in Caco-2 CRC cells, in which
FeCl3 led to a non-significant rise in ROS levels (Sup-
plementary Fig. S1C). Furthermore, ROS formation was
determined in HCT116 cells maintained under reduced
oxygen levels similar to HCEC. As observed before, hemin
increased ROS production in HCT116 cells in a dose-
dependent manner with slightly weaker effects as
observed under standard culture conditions (Supple-
mentary Fig. S2E).
We then set out to analyze the impact of hemin or FeCl3
on DNA damage induction using the alkaline Comet assay
with or without the DNA glycosylase Fpg. This enzyme
recognizes 8-Oxoguanine (8-oxoG) and catalyzes the
excision of the damaged base via ß-δ elimination, result-
ing in the generation of DNA single-strand breaks22.
Hence, this setup allows for the detection of both DNA
strand breaks and oxidative DNA damage (i.e., 8-oxoG).
Hemin significantly induced DNA strand breaks after 2 h
of incubation in both HCT116 and HCEC (Fig. 1e).
Interestingly, the Fpg-modified alkaline Comet assay
revealed a strong dose-dependent induction of oxidative
DNA damage in both cell types (Fig. 1f). In turn, inorganic
iron generated neither substantial levels of oxidative DNA
lesions nor DNA strand breaks (Fig. Fig. 1e, f), which is in
line with the lack of ROS production (Fig. 1). After 24 h of
incubation, DNA strand break level returned to baseline
levels except for HCEC treated with 100 µM hemin
(Supplementary Fig. S3A). Oxidative DNA damage was
still observed after hemin treatment in HCT116 cells,
although the levels were diminished as compared to those
after 2 h (Supplementary Fig. S3B). In HCEC, a massive
induction of oxidative DNA lesions was found at a dose of
100 µM hemin. It is noteworthy that FeCl3 showed almost
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no genotoxicity also after 24 h in both HCT116 cells and
HCEC (Supplementary Fig. S3A, B). Furthermore, ferrous
iron (FeSO4) was not genotoxic in HCEC (Supplementary
Fig. S3C). Taken together, our results demonstrate that
hemin, in contrast to inorganic iron, generates ROS, DNA
strand breaks and oxidative DNA damage in both normal
HCEC and CRC cells.
Heme iron, not inorganic iron, impairs viability
predominantly in HCEC and intestinal organoids
Having shown that hemin is genotoxic, its effects on cell
viability were determined after 72 h using the MTS assay.
Hemin led to a pronounced, dose-dependent reduction of
viability in HCEC, reaching about 25% viability at 200 µM
(Fig. 2a). HCT116 cells were generally more resistant
towards hemin treatment and showed only a moderate
decrease in viability at the highest hemin dose (Fig. 2b).
Caco-2 CRC cells also exhibited a lower sensitivity
towards hemin than HCEC, with a viability of 60% at
200 µM hemin (Fig. 2c). Interestingly, viability of HCEC
and the CRC cell lines were only slightly reduced by
inorganic iron (Fig. 2a–c and Supplementary Fig. S4E),
consistent with its weak effects on ROS and DNA damage
formation observed before. It should be noted that
HCT116 and Caco-2 cells maintained under reduced
oxygen tension (7% O2 like HCEC) displayed similar
sensitivity towards hemin as compared to the standard
culture conditions (Supplementary Fig. S4C, D). Further
Fig. 1 Time-dependent formation of ROS and oxidative DNA damage in HCEC and CRC cells by heme iron versus inorganic iron. a, c HCEC
were incubated for 30 min (a) or 2 h (c) with increasing doses of hemin or FeCl3 (0–200 µM). Reactive oxygen species (ROS) levels were assessed by
live cell staining and subsequent flow cytometry-based analysis. b, d HCT116 were treated for 30 min (b) or 2 h (d) and analyzed as described under
a. Data (a–d) is shown as mean + SEM (n ≥ 3, except for 20 µM in HCT116 at 2 h: n= 2). Ns: p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001, ****p < 0.0001
(versus respective control). e, f Cells were exposed to hemin (0–200 µM) or FeCl3 (200 µM) for 2 h. DNA strand break induction and formation of
oxidative DNA damage was determined by the alkaline Comet assay without (e) or with Fpg (f). Data are presented as mean + SEM (n ≥ 3). Ns: p >
0.05; *p < 0.05; **p < 0.01 (versus control).
Seiwert et al. Cell Death and Disease          (2020) 11:787 Page 3 of 16
Official journal of the Cell Death Differentiation Association
experiments revealed that other CRC cell lines (RKO,
LS174T) were also more resistant towards hemin than
HCEC (Supplementary Fig. S4A, B). Taken together,
heme triggered cytotoxicity was higher in HCEC as
compared to the different CRC cell lines tested, while
FeCl3 hardly affected viability in all cell lines. Finally,
murine intestinal organoids were established to study the
effects of hemin versus FeCl3 on their growth and viability
(Fig. 2d). Hemin caused a substantial reduction in orga-
noid viability already at 10 µM, with a further potentiation
at 50 µM (Fig. 2e). In contrast, FeCl3 only moderately
decreased organoid viability, which closely mirrors the
effects observed in HCEC (Fig. 2a, e). In conclusion, these
findings provided evidence that hemin reduces viability
predominantly in HCEC and intestinal organoids, while
various CRC cell lines are only modestly affected. More-
over, inorganic iron displayed weak toxicity in all cell
models and the intestinal organoids.
Uptake kinetics of heme iron and inorganic iron into HCEC
and CRC cells
Next, we wished to know whether the cellular iron
uptake might explain the observed differences between
heme iron and inorganic iron on the one hand as well as
HCEC and CRC cells on the other hand. To this end,
cells were incubated with different hemin and FeCl3
concentrations for up to 24 h. Cells were then harvested
and analyzed for their total cellular iron content (both
Fig. 2 Impact of heme iron and inorganic iron on cell and intestinal organoid viability. a–c HCEC (a), HCT116 (b) and Caco-2 (c) were treated
with increasing concentrations of hemin or FeCl3 (0–200 µM). Cell viability was determined after 72 h using the MTS assay. Data are given as mean +
SEM (n ≥ 3, triplicates). Ns: p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 (versus respective control). d Microscopic images of isolated
intestinal crypts (day 0) and the developing intestinal organoids (day 1 and 4). e Intestinal organoids were treated with hemin or FeCl3 for 24 h and
viability was determined by the MTT assay. Date are given as mean+ SEM (n= 2). Ns: p > 0.05; **p < 0.01; ****p < 0.0001.
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free iron and iron bound to proteins) using ICP-MS.
First, the iron content was assessed in HCEC, revealing a
time- and dose-dependent increase of the iron content
following hemin treatment (Fig. 3a). After 24 h, 200 µM
hemin resulted in an iron content of 131 ng/105 cells.
Inorganic iron was internalized even more efficiently,
with a maximum of 1200 ng iron/105 cells after 24 h (Fig.
3a). In HCT116 cells, a time- and dose-dependent
increase in cellular iron was detected upon hemin
exposure, reaching a maximum Fe content (~30 ng/105
cells) after treatment with 200 µM hemin for 24 h (Fig.
3b). Incubation with 200 µM FeCl3 resulted in a max-
imum Fe content already after 1 h, which then leveled
out to about 7 ng iron/105 cells after 24 h. As observed in
HCT116 and HCEC, hemin treatment resulted in a dose-
dependent increase of the cellular iron level in Caco-2
cells, with a maximum of 1200 ng Fe/105 cells after 8 h
(Fig. 3c). At the same time, incubation with 200 µM
FeCl3 raised cellular iron levels to 17 ng/10
5 cells. As
another readout for hemin uptake, the protein expres-
sion of HO-1 was analyzed in cell lysates form HCEC and
HCT116 after 8 and 24 h (Fig. 3d and Supplementary Fig.
S5C). HO-1 is responsible for the intracellular break-
down of hemin to ferrous iron, biliverdin and CO23. No
or very little HO-1 induction was detected after FeCl3
treatment in both cell types. In opposition to that, hemin
upregulated HO-1 expression in a dose-dependent
manner, with stronger effects in HCEC than in
HCT116 cells (Fig. 3d and Supplementary Fig. S5C). This
is likely attributable to the better internalization of
hemin into HCEC, resulting in up to 6-fold higher iron
content as compared to HCT116 (Fig. 3a vs. 3b). Fur-
thermore, a dose-dependent upregulation of ferritin
heavy chain (FtH) was observed after hemin exposure in
both cell types, which was also more prominent in HCEC
than in HCT116 cells and not induced by inorganic iron
(Supplementary Fig. S5D, E). FtH and ferritin light chain
(FtL) subunits assemble into the 24-mer ferritin (FTN),
Fig. 3 Uptake of hemin and inorganic iron into HCEC and CRC cells. a HCEC were incubated with hemin or FeCl3 for different periods (0, 0.25, 8
and 24 h) at the concentrations indicated. Cells were then collected and iron content was determined by ICP-MS as described. Data are depicted as
mean + SEM (n ≥ 3). b HCT116 cells were treated with hemin or FeCl3 and iron content was analyzed as mentioned above. Data are shown as mean
+ SEM (n= 7). c Caco-2 cells were treated and analyzed as described under a. Data are presented as mean + SEM (n ≥ 6). d HCEC and HCT116 cells
were exposed to hemin or FeCl3 for 24 h. Cells were harvested, lysed and subjected to Western blot analysis for heme oxygenase-1 (HO-1) and ferritin
heavy chain gene (FtH). Hsp90 was detected as loading control.
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which is known to sequester free iron released by HO-1
mediated breakdown of heme24. In summary, heme iron
and inorganic iron were taken up in a rather cell type-
dependent manner. Furthermore, the cellular iron con-
tents seem not to directly correlate with the observed
genotoxic and cytotoxic effects.
Hemin activates Nrf2 signaling and stimulates HO-1
expression in HCEC and HCT116 cells
We then analyzed the activation of the transcription
factor Nrf2 by hemin. Nrf2 is a major player in the cellular
response to oxidative stress, which results in its stabili-
zation and translocation from the cytosol into the
Fig. 4 Impact of hemin and inorganic iron on Nrf2 signaling in HCEC and CRC cells. a HCEC were exposed to hemin (0–100 µM) for 2 h. Cells
were fixed, processed for Nrf2 staining and analyzed by confocal microscopy. Representative images are shown. Nrf2 is depicted in green and nuclei
are shown in blue. Scale bar: 20 µm. b HCEC were treated with hemin (0–50 µM) for 8 h. Cells were fixed, processed for HO-1 staining and analyzed by
confocal microscopy. Representative images are shown. HO-1 is depicted in green and nuclei are shown in blue. Scale bar: 20 µm. c Quantitative
evaluation of Nrf2 staining shown in a. Nrf2 intensity was quantified by ImageJ. Data are given as mean + SEM (n= 2). ****p < 0.0001. d Quantitative
evaluation of HO-1 staining shown in b. HO-1 intensity was quantified by ImageJ and data are indicated as mean + SEM (n= 3). ****p < 0.0001.
e HCEC were incubated for 8 h with 100 µM hemin, 100 µM FeCl3, or 500 µM α-Lipoic acid (LA). Cell fractionation was performed as described.
Cytoplasmic and nuclear protein extracts were then analyzed by SDS-PAGE and western blot detection of Nrf2, HO-1 and FtH. PARP-1 served as
nuclear loading control, while Hsp90 was used as cytoplasmic loading control. f HCT116 were treated, processed and analyzed as stated under e.
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nucleus25. Treatment of HCEC with increasing con-
centrations of hemin (0–100 µM) for 2 h led to increased
Nrf2 staining intensity and its accumulation in the
nucleus as visualized by confocal microscopy (Fig. 4a, c
and Supplementary Fig. S5A). Furthermore, HO-1
expression and its subcellular localization were studied,
revealing a dose-dependent increase in HO-1 intensity
already detectable at 10 µM hemin after 8 h. As expected,
HO-1 was detected almost exclusively in the cytoplasm of
HCEC (Fig. 4b, d and Supplementary Fig. S5B). Moreover,
the subcellular localization of Nrf2 and HO-1 was studied
by Western blot analysis following cell fractionation.
Consistent with confocal microscopy, hemin increased
both Nrf2 and HO-1 levels in HCEC and promoted the
accumulation of Nrf2 in the nuclear fraction. Likewise,
hemin provoked FtH upregulation in the cytoplasm. In
contrast, inorganic iron provoked modest Nrf2 induction
without significantly upregulating HO-1 or FtH (Fig. 4e).
LA was included as a known activator of Nrf226, and thus
caused Nrf2 stabilization with concomitant nuclear
translocation. The lack of HO-1 induction by LA despite
the observed Nrf2 activation is consistent with the notion
that HO-1 induction by Nrf2 requires the inactivation of
the transcriptional repressor BACH-1 via heme bind-
ing27,28. Similar effects were observed in HCT116 cells,
although Nrf2 stabilization and particularly HO-1
expression were lower as in HCEC (Fig. 4f). Taken toge-
ther, Nrf2 and its downstream target HO-1 are rapidly
induced by hemin, which preferentially occurred
in HCEC.
Chemical inhibition or genetic ablation of HO-1
potentiates hemin-triggered ROS and oxidative DNA
damage
In order to study the role of HO-1 in cytoprotection and
to figure out, which intracellular iron forms (hemin or
inorganic iron produced by heme catabolism) are crucial
for the geno- and cytotoxicity, we made use of the HO-1
inhibitor zinc protoporphyrin (ZnPP) that blocks heme
breakdown29. First, hemin-triggered ROS formation was
analyzed in HCEC in the presence or absence of ZnPP.
The HO-1 inhibitor itself slightly elevated ROS levels,
while 50 µM hemin resulted in a pronounced increase in
ROS (Fig. 5a and Supplementary Fig. S6A). Intriguingly,
the combination of ZnPP and hemin strongly potentiated
ROS formation, indicating that hemin itself is catalyzing
ROS production (Fig. 5a and Supplementary Fig. S6A).
Using the same experimental setup, almost no effects
were observed in HCT116 cells (Fig. 5b and Supplemen-
tary Fig. S6B). To corroborate these results, HO-1 was
downregulated by siRNA in both cell types (Fig. 5c).
Treatment of HCEC with 50 µM hemin caused a strong
induction of HO-1 in untransfected cells or cells trans-
fected with scrambled RNA, while HCEC with siRNA
mediated HO-1 knockdown showed only very little
induction (Fig. 5c, left panel). As expected, hemin pro-
voked a robust upregulation of both Nrf2 and its down-
stream target FtH in HCEC independent of the HO-1
knockdown. In HCT116 cells, HO-1 knockdown pre-
vented its induction by hemin, similar to HCEC (Fig. 5c
right panel). The genetic abrogation of HO-1 had no
impact on Nrf2 and FtH induction following hemin
treatment, both of which were however not as prominent
as in HCEC (Fig. 5c). HO-1 knockdown moderately ele-
vated basal ROS levels and strongly promoted ROS gen-
eration in HCEC upon hemin treatment (Fig. 5d and
Supplementary Fig. S7A, B), which is in agreement with
the results obtained with ZnPP (Fig. 5a). In HCT116 cells,
siRNA mediated downregulation of HO-1 slightly
increased basal ROS levels and potentiated ROS forma-
tion only in the presence of 200 µM hemin (Fig. S7C, D),
consistent with the findings obtained for ZnPP treatment
(Fig. 5b). Afterwards, induction of DNA damage was
studied using the alkaline Comet assay with Fpg mod-
ification. Single treatment of HCEC with the inhibitor
already increased the level of oxidative DNA damage,
which was particularly obvious at a dose of 1 µM ZnPP
(Fig. 5e). Incubation with 50 µM hemin caused only little
DNA damage after 24 h as seen before (Fig. 5e and Sup-
plementary Fig. S3). In the presence of the HO-1 inhi-
bitor, both DNA strand breaks and oxidative DNA lesions
were massively elevated as compared to the single treat-
ments (Fig. 5e, f). Altogether, these findings strongly
suggest that hemin, but not its cellular degradation pro-
duct inorganic iron, is responsible for ROS generation and
DNA damage induction.
Inhibition or knockdown of HO-1 promotes hemin-
triggered cytotoxicity
Finally, we wished to know whether HO-1 inhibition by
ZnPP affects cell cycle progression and viability in cells
after hemin exposure. Hemin caused a dose-dependent
increase in the subG1-population of HCEC, indicative of
cell death (Fig. 6a and Supplementary Fig. S8A). HO-1
inhibition itself did not elevate the subG1-population as
compared to the control, but increased the number of
cells in G1-phase. Interestingly, combined treatment of
HCEC with hemin and the HO-1 inhibitor strongly
increased the subG1-population (Fig. 6a and Supple-
mentary Fig. S8A). The cell cycle distribution of HCT116
cells was only significantly affected at a dose of 200 µM
hemin (Fig. 6b and Supplementary Fig. S8B). Treatment
of HCT116 with the HO-1 inhibitor resulted in a mod-
erate increase of cells in S-phase at the expense of a
reduced G2/M-phase (Fig. 6b and Supplementary Fig.
S8B). In contrast to the findings in HCEC, HO-1 inhibi-
tion did not augment the subG1-population induced by
high hemin concentrations in HCT116, but rather shifted
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cells from S-phase to G2/M-phase (200 µM hemin vs.
200 µM hemin + ZnPP). Subsequently, cell viability was
assessed using the MTS assay in both HCEC and HCT116
cells. The HO-1 inhibitor itself slightly improved viability
of HCEC, while treatment with 100 µM hemin caused a
significant reduction in viability (Fig. 6c). Intriguingly, the
presence of the HO-1 inhibitor potentiated the hemin-
dependent loss of viability in HCEC, which is in agree-
ment with the findings described above. This was further
confirmed using the ATP assay as endpoint, revealing
strongly enhanced cytotoxicity if HO-1 dependent
degradation of hemin is blocked using ZnPP (Supple-
mentary Fig. S9A, B). Next, HO-1 expression was silenced
by siRNA in both HCEC and HCT116 cells. Knockdown
of HO-1 potentiated hemin-induced cytotoxicity in
HCEC (Fig. 6e), which is in line with the experiments
using the HO-1 inhibitor ZnPP (Fig 6a, c). In contrast to
that, knockdown of HO-1 in HCT116 cells only moder-
ately affected viability at 200 µM hemin (Fig. 6f), con-
firming the results obtained with ZnPP treatment (Fig. 6b,
d). In summary, the results highlight the cytoprotective
role of HO-1 following hemin exposure and reveal that
Fig. 5 Influence of HO-1 on hemin-triggered ROS and oxidative DNA damage in HCEC and CRC cells. a HCEC were incubated with hemin (0 or
50 µM) in the absence or presence of the HO-1 inhibitor zinc protoporphyrin (ZnPP; 0.5 or 1 µM) for 24 h. Cells were stained with the CM-H2DCFDA
dye and levels of reactive oxygen species (ROS) were assessed by flow cytometry. Data are presented as mean + SEM (n ≥ 3). *p < 0.05; **p < 0.01;
***p < 0.001. b HCT116 cells were treated and analyzed as described above. Data are given as mean + SEM (n= 4). *p < 0.05; **p < 0.01; ****p <
0.0001. c HCEC and HCT116 cells were transiently transfected with scrambled (scr) or HO-1-specific siRNA. 24 h after transfection, cells were treated
with hemin and incubated for another 24 h. Whole-cell extracts were analyzed by SDS-PAGE and immunoblot detection of Nrf2 and FtH.
Hsp90 served as loading control, whereas HO-1 was visualized to confirm knockdown. d Knockdown of HO-1 in HCEC followed by hemin exposure
for 24 h and analysis of ROS formation. ROS were measured by flow cytometry as stated above. Data are given as mean + SEM (n= 4). *p < 0.05;
****p < 0.0001. e HCEC were treated with hemin (0 or 50 µM) in the absence or presence of the HO-1 inhibitor ZnPP (ZnPP; 0.5 or 1 µM) for 24 h. Cells
were then subjected to the alkaline Comet assay with or without Fpg. OTM, olive tail moment. Data are given as mean + SEM (n= 5). Ns: p > 0.05;
*p < 0.05; **p < 0.01; ***p < 0.001, ****p < 0.0001. f Representative pictures of the data shown in e.
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hemin, but not its breakdown product inorganic iron,
causes cytotoxicity. The major findings have been sum-
marized in a scheme presented in Fig. 7.
Discussion
The present work compared the genotoxic and cyto-
toxic effects of hemin and inorganic iron side-by-side in
HCEC versus CRC cell lines. First, we demostrated that
hemin (≥20 µM) caused substantial ROS formation in a
concentration-dependent manner in both HCEC and
CRC cells, whereas inorganic iron had only very little or
no effects. Notably, this held true for both ferric and
ferrous iron. In line with the latter finding, ferric iron
added as ferric nitrilotriacetate (Fe-NTA) promoted ROS
formation in HT29 CRC cells only at a very high dose of
1000 µM30. Similarly, treatment of the hepatic cell line
HH4 with ferric ammonium citrate resulted in sig-
nifcantly increased ROS levels only at concentrations
above 1000 µM, while incubation of cells with 100 µM
ferric ammonium citrate or ferric chloride did not aug-
ment basal ROS levels31,32. In support of our results,
another study also reported ROS generation in HCT116
and RKO cells treated with 100 µM hemin33. Further-
more, we showed that hemin, in contrast to inorganic
iron, caused DNA strand breaks as well as oxidative DNA
damage (i.e., 8-oxoG) in HCEC and CRC cells. DNA
Fig. 6 Influence of HO-1 on hemin-triggered cell cycle distribution and cytotoxicity in HCEC and CRC cells. a HCEC were treated with hemin
(0–100 µM) in the absence or presence of the HO-1 inhibitor zinc protoporphyrin (ZnPP; 2.5 µM) for 24 h and collected for cell cycle analysis by flow
cytometry. Data were evaluated by BD FACS Diva software and are shown as mean + SEM (n= 4). Statistical evaluation performed for subG1
population (white bars). *p < 0.05; **p < 0.01; ****p < 0.0001. b HCT116 cells were treated and analyzed as described above. Data are given as mean +
SEM (n ≥ 3). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. c HCEC were treated as described in a and cell viability was assessed using the MTS
assay. Data are shown as mean + SEM (n ≥ 2, triplicates). **p < 0.01; ****p < 0.0001 d HCT116 cells were treated and analyzed as described in a. Data
are given as mean + SEM (n= 2, triplicates). e HCEC were transiently transfected with scrambled (scr) or HO-1-specific siRNA. 24 h following
transfection, cells were treated with increasing hemin concentrations for another 24 h. Cell viability was determined by the MTS assay. Data are
shown as mean + SEM (n= 4, triplicates). Ns: p > 0.05; ***p < 0.001, ****p < 0.0001. f HCT116 cells were transiently transfected with scrRNA or HO-1
specific siRNA. Further treatment and analysis as described under e. Data are shown as mean + SEM (n ≥ 3, triplicates). Ns: p > 0.05; **p < 0.01.
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strand break induction was previously observed in other
CRC cell lines (i.e., Caco-2 and HT29) and in primary
colonocytes exposed to hemin at concentrations
≥100 µM14,34,35. DNA strand break formation was also
detected in isolated colonocytes from mice fed with red
meat36. To the best of our knowledge, the present study is
the first that demonstrated hemin mediated formation of
8-oxoG in HCEC or CRC cells. Whether or not this
occurs also in vivo following dietary heme intake has to be
elucidated in future studies. In agreement with the lack of
genotoxicity for inorganic iron (Fe2+ and Fe3+) observed
herein, ferric iron (applied as Fe-NTA) was reported to
cause DNA strand breaks only at very high doses
(≥500 µM) in colon adenoma and primary colon cells37.
This is further supported by the finding that dietary ferric
citrate caused significantly lower levels of the DNA strand
break marker γ-H2AX in the colon mucosa of B6/J mice
as compared to a diet with 2.5 % hemoglobin18.
It has recently been calculated that consumption of
100–500 g red meat (beef) will result in luminal heme
concentrations ranging from 17–85 µM in humans35.
Furthermore, data are available from rodent studies, in
which the animals were fed with various dietary heme
sources (e.g. beef, black pudding, hemin, hemoglobin,
processed meat). Heme concentrations between
19–1097 µM were determined in fecal water obtained
from the animals16,38,39, indicating that high heme con-
centrations can occur in the large intestine following its
dietary uptake. Overall, the heme concentrations used in
our study (20–200 µM) are in the range of those expected
in humans and measured in fecal water from animal
feeding studies.
Since ROS formation and DNA damage can both trigger
cytotoxic effects, this issue was addressed using different
endpoints. On the one hand, our experiments revealed
that inorganic iron did neither affect cell cycle distribution
nor caused cytotoxicity in HCEC, HCT116 cells and
murine intestinal organoids, although being efficiently
taken up particularly in HCEC as attested by ICP-MS
analysis of the cellular iron content. This is pretty well in
line with the observed lack of substantial ROS formation
and genotoxicity in our study. On the other hand, hemin
was demonstrated to be cytotoxic in a dose-dependent
manner in non-malignant HCEC and murine intestinal
Fig. 7 Model of heme-triggered DNA damage and cytotoxicity in HCEC versus CRC cells and role of HO-1. a Heme iron is taken up into HCEC,
where it catalyzes the formation of reactive oxygen species (ROS) and induces oxidative DNA lesions as well as DNA strand breaks (indicated by red
asterisks). This finally results in cytotoxicity, which is more prominent in HCEC than in CRC cell lines. In contrast, internalized inorganic iron causes little
ROS production and DNA damage, and only slightly impairs cell viability. Heme-dependent ROS formation activates the transcription factor Nrf2,
which shuttles from the cytoplasm to the nucleus, where it drives the transcription of its target genes such as heme oxygenase-1 (HO-1). This enzyme
degrades heme to Fe2+, carbon monoxide (CO) and biliverdin (BV). Concomitant to HO-1 induction, ferritin heavy chain gene (FtH) is upregulated by
hemin. Genetic abrogation of HO-1 by siRNA or its pharmacological inhibition by ZnPP potentiated heme-induced ROS, DNA damage and cell death,
strongly suggesting that heme iron, and not its breakdown product Fe2+, initiates ROS formation and thus DNA damage induction. b Internalization
of heme iron and inorganic iron in CRC cells. Similar to HCEC, inorganic iron causes little ROS production and DNA damage, and only slightly impairs
viability in CRC cells. Hemin is taken up differentially into CRC cells (Caco-2 > HCT116), causing less ROS formation and oxidative DNA damage as in
HCEC. Furthermore, CRC cells are in general more resistant against hemin-triggered cytotoxicity and HO-1 abrogation moderately affects cell survival
in the presence of high heme concentrations. This figure was created using Servier Medical Art templates, which are licensed under a Creative
Commons Attribution 3.0 Unported License; https://smart.servier.com.
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organoids. Interestingly, CRC cell lines were generally
more resistant in the order LS174T > HCT116 > Caco-2 ≈
RKO. One explanation for these findings could be dif-
ferences in the cellular uptake efficiency and kinetics of
both inorganic iron and heme iron. Ferric iron needs to be
reduced for its intestinal uptake, which is catalyzed by
ferric reductases such as the duodenal cytochrome B
together with reducing compounds (e.g., dietary vitamin
C)40. Ferrous iron is then mainly internalized by the
divalent metal transporter 1 (DMT1)41. Screening of the
used cell lines by western blot analysis revealed differ-
ential DMT1 expression (Supplementary Fig. S5F), with
the highest expression levels in Caco-2 and HCT116 cells.
HCEC displayed rather low DMT1 expression, but
internalization of inorganic iron was better than in
HCT116 and Caco-2 cells. This may be attributable to the
required supplementation of the HCEC cell culture
medium with transferrin (2 µg/ml ≈ 25 µM), which pro-
motes the uptake of ferric iron by receptor-mediated
endocytosis. Two pathways were described for the inter-
nalization of heme into enterocytes. One pathway seems
to involve receptor-mediated endocytosis mediated by a
still unknown protein42. Moreover, an intestinal heme
transporter called HCP-1 was identified4, which was also
discovered as an intestinal folate transporter in a sub-
sequent study43. Western blot detection of HCP-1 in the
cell lines used in this study revealed high levels in HCEC
and RKO cells, whereas HCT116 and Caco-2 cells dis-
played only low expression (Supplementary Fig. S4F).
Importantly, total cellular iron levels were determined by
ICP-MS and showed higher levels in HCEC than in
HCT116 cells following incubation with hemin, which
could thus be responsibe for the stronger cytotoxic effects
observed in HCEC. However, hemin exerted a weaker
cytotoxicity in Caco-2 cells despite even higher iron levels
as compared to HCEC. Furthermore, RKO cells displayed
a moderate sensitivity towards hemin similar to Caco-2
cells, but expressed much higher HCP-1 levels. These
findings indicate an involvement of another, HCP-1
independent heme uptake mechanism and highlights the
need to measure cellular iron concentrations as done in
the present study. It should also be mentioned that
intracellular iron levels are further controlled by efflux
transporters as described elsewhere7.
As the cellular iron levels not directly correlate with the
observed cytotoxicity in HCEC and the CRC cell lines,
other factors likely contribute to the resistance of CRC
cells towards hemin. The tumor suppressor protein p53,
which is activated by genotoxic stress and can trigger cell
death, could be considered here given that it is frequently
mutated in CRC cells44. However, both the resistant
HCT116 and LS174T CRC cells as well as the sensitive
HCEC express wildtype p5345,46, thus rather excluding
this possibility. Previous studies showed an increased
cytotoxicity of fecal water from hemin or hemoglobin fed
rodents and its constitiuent 4-HNE in non-transformed
murine colonocytes with wildtype APC17,18. Intriguingly,
murine colonocytes harboring a mutated APC allel
(APCMin/+) were more resistant, which could be due to
the higher expression of enzymes implicated in HNE
detoxification19. Among the human CRC cell lines tested
here, LS174T, HCT116 and RKO cells express wildtype
APC, while Caco-2 cells bear APC mutations47,48. Thus,
no correlation was observed in these cell lines between
their sensitivity to hemin and their APC status. Consistent
with this finding, murine APC+/+ and APCMin/+ colo-
nocytes displayed similar reduction in viability after
treatment with hemin18.
Furthermore, we demonstrated that hemin causes
Nrf2 stabilization and its translocation into the nucleus of
HCEC, which was followed by a robust induction of
cytosolic HO-1. In contrast, inorganic iron had little effect
on Nrf2 levels and failed to induce HO-1, which goes
along with the absence of oxidative stress. A similar
upregulation of Nrf2 was detected in murine colonocytes
exposed to fecal water from hemoglobin- and beef-fed
rats, which was attenuated by former trapping of reactive
aldehydes present in fecal water20. Further evidence for
Nrf2 activation came from a feeding study in mice, which
received hemin or ferric citrate as control for up to
14 days. Hemin-fed mice displayed a fast and sustained
upregulation of several Nrf2 target genes including
catalase, glutathione S-transferase and heme oxygenase
1 (Hmox-1)11,49. Altogether, these findings emphasize the
important role of Nrf2 signaling in response to oxidative
stress triggered by heme iron. Furthermore, we showed
that hemin also stimulated FtH expression in a dose-
dependent manner, which paralleled the induction of HO-
1. FtH is a known Nrf2 target gene50 and is also controlled
on the translational level by iron-regulatory proteins in a
time-dependent manner51. Nrf2 is responsible for basal
Fth1 expression and induces ferritin expression upon
oxidative stress52. In line with our findings, hemin was
reported to upregulate the expression of FtH in K562
human erythroleukemic cells53.
To elucidate the role of HO-1 we used ZnPP as com-
petitive HO-1 inhibitor and, in addition, performed a
siRNA-mediated knockdown of HO-1, thereby revealing
strongly increased ROS generation and DNA damage
induction (i.e. DNA strand breaks, 8-oxoG) in HCEC.
This is very likely attributable to the blocked heme cata-
bolism and the concomitant accumulation of intracellular
free heme. Genetic or chemical abrogation of HO-1 in
HCEC potentiated hemin-dependent cytotoxicity as evi-
denced by cell viability assays and analysis of cell cycle
distribution. Notably, HCT116 cells were almost
unaffected after incubation with comparable doses of
hemin and ZnPP. Our findings clearly demonstrate a
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cytoprotective role for HO-1 in normal human colono-
cytes and further indicate that free heme, but not free iron
generated following heme catabolism, is mainly respon-
sible for the genotoxic and cytotoxic effects. In this regard,
it is important to mention that free iron produced
from heme by HO-1 is quickly neutralized by diverse
mechanisms, such as the upregulation of FtH as described
above and gene induction of iron efflux pumps24. Fur-
thermore, HO-1 mediated degradation of heme generates
biliverdin and the gasotransmitter CO6. Biliverdin is
transformed into bilirubin by biliverdin reductase, which
is known to possess antioxidative activity54. CO is also
involved in the cytoprotective effects exerted by HO-124.
Interestingly, HO-1 induction and CO generation were
reported to promote the repair of DNA double strand
breaks presumably via ATM as shown in Hmox-1−/− mice
and fibroblasts derived thereof55. These mechanisms
could further add to the observed increase in ROS for-
mation and DNA strand break induction in HCEC treated
with hemin under HO-1 inhibition. Finally, the cytopro-
tective function of HO-1 demonstrated here in human
colonocytes is consistent with the high ROS levels and
decreased survival of Hmox-1−/− embryonic fibroblasts
exposed to hemin56.
In conclusion, our study provided evidence that free
heme iron, but not its breakdown product inorganic iron,
plays a pivotal role in ROS formation and DNA damage
induction in human colonocytes. HO-1 was further
revealed to confer protection against the detrimental
effects of hemin. Interestingly, CRC cell lines were gen-
erally more resistant to the cytotoxic effects of hemin than
normal colonocytes, which might favor the outgrowth of
neoplastic cells in vivo and could thereby promote
intestinal carcinogenesis.
Material and methods
Cell culture and treatment
Non-transformed human colon epithelial cells (HCEC
1CT) were kindly provided by Prof. Jerry W. Shay
(Department of Cell Biology, UT Southwestern Medical
Center, Dallas, USA). Cells were isolated from normal
human colonic biopsies and immortalized by CDK4- and
hTERT-transfection as described46. HCEC were grown in
a nitrogen incubator with reduced oxygen levels (7% O2)
and 5% CO2 at 37 °C in 4:1 DMEM GlutaMax/Medium
199 (ThermoFisher Scientific, Darmstadt, Germany). The
medium was supplemented with 2% cosmic calf serum
(Hyclone, GE Healthcare, Hamburg, Germany), 25 ng/ml
human epidermal growth factor, 1 µg/ml hydrocortisone,
10 µg/ml insulin from bovine pancreas, 2 µg/ml transfer-
rin, 5 nM sodium selenite and 50 µg/ml gentamycin sul-
fate (all from Sigma, Schnelldorf, Germany).
HCT116 cells were generously provided by Prof. Bert
Vogelstein (John Hopkins University, Baltimore, USA)
and obtained from the Core Cell Center (John Hopkins
University). RKO cells were a kind gift of Prof. Oliver H.
Krämer (Institute of Toxicology, University Medical
Center, Mainz, Germany). RKO and HCT116 cells were
cultured in DMEM containing 10 % fetal calf serum (FCS)
(PanBiotech Aidenbach, Germany) and 1% penicillin/
streptomycin (p/s). Caco-2 cells were purchased from
CLS Cell Lines Service (Eppelheim, Germany) and
maintained in MEM with 10% FCS, 1% p/s and non-
essential amino acids. LS174T cells were a kind gift of
Prof. Thomas Brunner (University of Konstanz, Konstanz,
Germany) and cultured in IMDM medium (Pan Biotech,
Aidenbach, Germany) with 10% FCS and 1% p/s. CRC cell
lines were maintained at 37 °C in a humidified atmosphere
of 5% CO2 under standard culture conditions (∼20% O2).
For selected experiments, CRC cells were cultured under
hypoxic conditions (7% O2) in the nitrogen incubator. Cell
culture medium and supplements were obtained from Life
Technologies (Darmstadt, Germany) unless stated other-
wise. Cell lines were mycoplasma negative as demon-
strated by PCR and immunofluorescence microscopy with
nuclear staining. All cell lines were authenticated as
described previously57,58.
Hemin (Fe3+ protoporphyrin IX chloride; Sigma,
Schnelldorf, Germany) was dissolved in 20mM sodium
hydroxide (NaOH), while ferric chloride (FeCl3) and fer-
rous sulfate (FeSO4), both purchased at Sigma, were dis-
solved in water to obtain stock concentrations of 1 mM
each. Zinc protoporphyrin (ZnPP; Enzo Life Science,
Farmingdale, USA) was dissolved in DMSO at a final
concentration of 5 mM.
Transient transfection with siRNA tageting HO-1
Knockdown of HO-1 was performed using siGENOME
SMARTpool siRNA from Dharmacon (Lafayette, USA).
Cells grown in 6 well or 96 well plates were transfected at
40% confluency with 20 nM siRNA using Lipofectamine®
RNAimax (Invitrogen, Darmstadt, Germany). Scrambled,
non-sense siRNA (20 nM; Dharmacon, Lafayette, USA)
was included as negative control. 24 h after transfection,
cells were treated with hemin for different incubation
periods and analyzed as indicated. HO-1 knockdown was
checked by SDS-PAGE and western blot detection.
Generation of murine intestinal organoids and assessment
of viability
Isolation of intestinal crypts, ex vivo culture and
expansion to intestinal organoids were essentially per-
formed as described59. C57BL6/J mice (8–12 weeks) were
sacrificed followed by the preparation of the small intes-
tine. The organ was opened longitudinally and cut into
1–2 cm pieces after villi had been scraped off with a
microscope slide. The tissue slices were washed with ice-
cold PBS and then incubated in PBS containing 2mM
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EDTA for 30 min at 4 °C on a rotator. Subsequently, PBS/
EDTA was removed and replaced by PBS. After gentle
shaking, the supernatant was monitored by light micro-
scopy for residual villi and containing crypts. This process
was repeated until the villi/crypt ratio in the supernatant
was optimal, showing the highest number of intact crypts.
The suspension was then filtered through a 70 µm cell
strainer (BD Biosciences, Heidelberg, Germany) to
remove residual villi, pelleted by centrifugation and crypts
were resuspended in PBS for counting. After another
centrifugation step, crypts were resuspendend in Matrigel
(BD Biosciences) at the desired density (typically 100–300
crypts per 8 µl of Matrigel). Crypts were seeded into a flat
bottom 96 well plate by applying a droplet of 8 µl Matrigel
to each well, which was allowed to polymerize at 37 °C for
30min. Afterwards, 80 µl of complete crypt culture
medium was added consisting of advanced DMEM/F12,
10 mM HEPES, 100 U/ml penicillin, 100 mg/ml strepto-
mycin, 20 mg/ml nystatin, 1 mM N-acetyl cysteine (all
from Sigma, Schnelldorf, Germany), 0.1% BSA (Carl
Roth, Karlsruhe, Germany), 2 mM L-glutamine, 1x
B27 supplement, 1x N2 supplement (all from Life Tech-
nologies, Darmstadt, Germany), 50 ng/ml murine EGF,
100 ng/ml murine Noggin and 500 ng/ml human R-
spondin-1 (all from Peprotech, Hamburg, Germany).
Intestinal organoids were maintained at 37 °C and 5% CO2
in the incubator for 3 days. Organoids were then exposed
to increasing concentrations of hemin or ferric chloride
(0–100 µM) for 24 h. Viability was determined using the
MTT assay. To this end, MTT solution was added to the
organoid culture at a final concentration of 500 µg/ml.
After an incubation for 1 h, the medium was discarded
and 20 µl of 2% SDS solution was added in order to
solubilize the Matrigel. After another 1 h of incubation,
the solution was discarded and the reduced MTT was
solubilized with 80 µl DMSO for 1 h. Absorbance at
562 nm was determined using a microplate reader (Sun-
rise Tecan Reader, Crailsheim, Germany). Solvent treated
organoids were defined as 100% viable.
Determination of cell viability by ATP and MTS assay
Viability of CRC cells and HCEC was determined using
the Cell Titer 96® AQueous One Solution Cell Pro-
liferation Assay (Promega, Mannheim, Germay) as
reported58. Cells (HCT116: 5 × 103/well; Caco-2: 5 × 103/
well; LS174T: 5 × 103/well, RKO: 5 × 103/well and HCEC:
1 × 103/well) were grown overnight and then treated with
increasing concentrations of hemin or iron chloride
(0–200 µM as indicated). NaOH or H2O served as
respective solvent controls. After 72 h, viability was
measured using a microplate reader (Sunrise Tecan
Reader, Crailsheim, Germany) according to the manu-
facturer’s instructions. To analyze the effects of hemin in
the absence or presence of the HO-1 inhibitor ZnPP,
HCT116 cells (24 h: 1.5 × 104 cells/well; 72 h: 5 × 103 cells/
well) or HCEC (24 h: 2.5 × 103/well; 72 h: 1 × 103/well)
were grown in white 96-well plates overnight. Cells were
then preincubated with ZnPP (0–2.5 µM) for 1 h followed
by the addition of hemin (0–100 µM). Viability was
assessed after 24 or 72 h using the MTS assay as described
above. Furthermore, viability was determined with the
CellTiter-Glo®Luminescent Cell Viability Assay (Pro-
mega, Mannheim, Germany), which measures the cellular
ATP level. The assay was performed according to the
manufacturer’s instructions with a MicroLumat Plus 96-
well plate reader (Berthold, Bad Wildbad, Germany).
ICP-MS analysis to determine total cellular iron levels
Caco-2 cells (1 × 105), HCT116 cells (5 ×105) or HCEC
(2 × 105) were grown in 6 cm dishes and treated with
hemin or ferric chloride for 0.25, 1, 8 and 24 h. Cells were
trypsinized and harvested by centrifugation. The pellets
were then digested in 0.5 ml H2O2/HNO3 (1:1) overnight
at 95 °C. The residue was dissolved in 1.5 ml 10% HNO3
with 0.5 µg/l Rh (Merck, Darmstadt, Germany) as internal
standard and diluted if required. Quantification was per-
formed with an external calibration curve ranging from
0.5–100 µg/l Fe (Spetec, Erding, Germany). The mea-
surements were conducted with a tandem mass spectro-
meter (8800 triple quadrupole ICP-MS, Agilent
Technologies, Böblingen, Germany) equipped with two
quadrupols (Q1 and Q2) as well as a collision and reaction
cell with O2 (0.3 ml/min) as collision gas. Quantification
was carried out directly using the 56Fe+ ion (Q1 and Q2
mass-to-charge (m/z) ratio 56) or indirectly using the
56Fe16O+ ion (Q1 m/z 56 and Q2 m/z 72).
SDS–PAGE and Western blot
HCT116 cells (3 × 105) or HCEC (2 × 105) were seeded
in 3.5 cm dishes and allowed to adhere overnight. Fol-
lowing treatment with hemin or ferric chloride as indi-
cated, cells were harvested in 1× Lämmli loading buffer.
Western blot analysis was essentially performed as
described57. Equal protein amounts were separated by
SDS-PAGE followed by transfer onto a nitrocellulose
membrane (Amersham™ Protran®, GE Healthcare, Frei-
burg, Germany) with a wet blot chamber (BioRad,
München, Germany). Membranes were then blocked with
5% nonfat dry milk (Carl Roth) in Tris-buffered saline
(TBS)/0.1% Tween-20 for 1 h at RT. Primary antibody
incubation was conducted overnight at 4 °C followed by
three washing steps (3 × 5min) in TBS/0.1% Tween-20.
Membranes were then incubated with appropriate sec-
ondary antibodies for at least 1 h at RT. After 3 × 5min
washing, proteins were detected using Western Light-
ning® Plus-ECL (Perkin Elmer, Rodgau, Germany). The
following primary antibodies anti-ferritin heavy chain
gene (FtH; mouse monoclonal, B-12; no. sc-376594),
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anti-heat shock protein 90 (Hsp90) α/β (mouse mono-
clonal; no. sc-13119), anti-heme carrier protein-1 (HCP-1;
B-4; mouse monoclonal; no. sc-393460) were all pur-
chased from Santa Cruz Biotechnology, Heidelberg,
Germany. The primary antibodies anti-divalent metal
transporter-1 (DMT1; rabbit polyclonal; no. GTX64686),
anti-heme oxygenase-1 (HO-1; rabbit polyclonal; no.
GTX101147) and anti-nuclear factor E2-related factor
(Nrf2; rabbit monoclonal; no. GTX103322) were obtained
from GeneTex, Irvine, California, USA. Secondary anti-
bodies conjugated with horseradish-peroxidase were from
Santa Cruz (anti-mouse) and Cell Signaling (anti-rabbit).
Measurement of ROS formation by flow cytometry
HCT116 cells (3 × 105/well), Caco-2 cells (2 × 105/well)
and HCEC (2 × 105/well) were grown overnight in six-well
plates. Cells were treated with increasing doses of hemin
or ferric chloride (0–200 µM) for up to 24 h. Incubation
with 200 µM H2O2 (Merck, Darmstadt, Germany) for
20min in PBS served as positive control. Levels of reactive
oxygen species (ROS) were determined as reported60.
Briefly, cells were rinsed twice with pre-warmed PBS and
then were loaded with 2.5 µM CM-H2DCFDA (Invitro-
gen, Darmstadt, Germany) for 30min at 37 °C using
phenol red- and serum-free medium. Following a washing
step with PBS, cells were harvested using Trypsin/EDTA,
pelleted by centrifugation and resuspended in PBS.
Finally, cells were analyzed by flow cytometry using a BD
FACSCanto II (BD Biosciences, Heidelberg, Germany)
and evaluated using BD FACSDiva software.
Assessment of cell cycle distribution by flow cytometry
Cell cycle analysis was performed as described61.
HCT116 cells (5 × 105) and HCEC (3 × 105) were grown
overnight in 6 cm dishes and then exposed to increasing
doses of hemin or ferric chloride in the presence or
absence of ZnPP as indicated. After 24 h of incubation,
cells were harvested and washed twice in PBS. Following
ethanol precipitation at −20 °C for 1 h, the pellet was
resuspended in PBS containing RNase A (20 μg/ml) and
incubated for 1 h at RT. Subsequently, propidium iodide
(PI; Sigma) was added to a final concentration of 10 μg/
ml, and cells were analyzed for DNA content by flow
cytometry using BD FACSCanto II (BD Biosciences). Cell
cycle distribution was analyzed with BD FACSDiva
software.
Detection of DNA damage by the Comet assay
HCT116 cells (2.5 × 105) and HCEC (1.5 × 105) were
seeded in 3.5 cm dishes and grown overnight. Cells were
then incubated with increasing concentrations of hemin or
ferric chloride for 2 or 24 h as stated. As positive control,
the cells were treated with 50 µM tert-butyl hydroperoxide
(t-BOOH; Sigma) for 20min. Cells were then harvested
and processed for the alkaline Comet assay as descri-
bed62,63. Cells embedded in 0.5% low melting point agar-
ose were transferred onto a slide pre-coated with agarose.
The slides were incubated for 1 h in lysis buffer consisting
of 2.5M sodium chloride (NaCl), 100 mM ethyldiamine
tetraacetic acid (EDTA), 1% Triton X-100 and 10mM Tris
pH 10. As a next step, DNA unwinding was conducted in
electrophoresis buffer (300mM NaOH, 1mM EDTA pH
13) for 25min at 4 °C. Samples were then subjected to
electrophoresis for 15min at 25 V and 300mA followed by
a neutralization step with 0.4M Tris pH 7.5. After fixation
in 100% ethanol, the air-dried samples were stained with
50 μg/ml PI (Sigma). Comets were analyzed by fluores-
cence microscopy using an Olympus BX50 microscope
equipped with a ColorView camera (Olympus, Münster,
Germany). In each experiment, at least 50 cells were
scored using Comet IV software (Perceptive Instruments
Ltd., Bury St Edmunds, UK).
To detect oxidative DNA damage (i.e., 8-Oxoguanine),
the Formamidopyrimidine-DNA glycosylase (Fpg)-mod-
ified alkaline Comet assay was used64. After cell lysis, the
slides were incubated in a buffer containing Fpg (1 µg/ml),
40 mM HEPES, 0.1M KCL, 0.5 mM EDTA and 0.2 mg/ml
BSA, pH 8.0 for 37min at 37 °C. Subsequently, the pro-
tocol was continued with the DNA unwinding step as
described above.
Confocal microscopy of fixed cells
HCEC (1 × 105 cells) were seeded on coverslips in 6-well
plates. After 24 h, HCEC were treated with increasing
doses of hemin (0–100 µM) and incubated for 8 h.
Immunofluorescence staining was performed as repor-
ted65. Upon fixation with methanol at −20 °C for 10min,
cells were washed twice with PBS and then incubated for
1 h with blocking solution consisting of 5% bovine serum
albumin (BSA) in PBS with 0.3% Triton X-100. The
samples were incubated with an anti-Nrf2 antibody
(Genetex; diluted 1:500 in PBS/0.2% Triton X-100) or an
anti-HO1 antibody (Genetex; diluted 1:1,000 in PBS/0.2%
Triton X-100) overnight at 4 °C. After several washing
steps, the samples were incubated with an appropriate
Alexa488-coupled goat-anti-rabbit secondary antibody
(Life Technologies; 1:400 in PBS plus 0.2% Triton X-100).
Nuclei were finally counterstained using TO-PRO-3 (Life
Technologies; 1:100 in PBS). Coverslips were mounted
using VectaShield (Vector Labs, Burlingame, USA) and
analyzed with a Zeiss Axio Observer.Z1 microscope
equipped with a confocal LSM710 laser-scanning unit
(Zeiss, Oberkochen, Germany). Pictures were analyzed
and processed using Image J.
Cell fractionation
Cells were treated as indicated and subjected to
cell fractionation according to a protocol published
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recently65. Protein content of the cytoplasmic and
nuclear fractions was determined by the Bradford assay.
SDS–PAGE and Western blot analysis were conducted as
described above.
Statistics
Experiments were performed independently three
times, except when otherwise stated. Representative
experiments are displayed. Values are presented as means
+ standard error of the means (SEM). Data were analyzed
for outliers with the Grubbs’ test using GraphPad Prism
7.0 software. Statistical analysis was then performed in
GraphPad Prism using two-sided Student’s t-test and
statistical significance was defined as p < 0.05.
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